BIRC5 and cancer: Subsequent studies of single-cell clone separation by cell sorting of peptide-specific CTLs showed that each CTL clone was not only peptide-specific but also cytotoxic against human cancer cells in the context of the expression of both HLA-A24 and survivin molecules [159].